(Z)-3-(2-(4-fluorophenylamino)-4-oxothiazol-5(4H)-ylidene)-1-methylindolin-2-one

ID: ALA212045

PubChem CID: 135418652

Max Phase: Preclinical

Molecular Formula: C18H12FN3O2S

Molecular Weight: 353.38

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1C(=O)/C(=C2\SC(Nc3ccc(F)cc3)=NC2=O)c2ccccc21

Standard InChI:  InChI=1S/C18H12FN3O2S/c1-22-13-5-3-2-4-12(13)14(17(22)24)15-16(23)21-18(25-15)20-11-8-6-10(19)7-9-11/h2-9H,1H3,(H,20,21,23)/b15-14-

Standard InChI Key:  ONHADLRFUHGNIQ-PFONDFGASA-N

Molfile:  

     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
   -4.3450  -18.8858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3461  -19.7128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6317  -20.1254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6335  -18.4733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9185  -18.8822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9136  -19.7128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1222  -19.9649    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6378  -19.2900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1301  -18.6210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8133  -19.2851    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8798  -17.8353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0965  -17.5721    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1013  -16.7476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8871  -16.4974    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3678  -17.1673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4373  -16.2590    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2672  -16.6877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2437  -17.5102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9472  -17.9388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6716  -17.5432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6882  -16.7145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9840  -16.2896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3765  -17.9709    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1923  -17.1709    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8628  -20.7476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  3  6  2  0
  1  2  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 11  1  0
  5  4  2  0
 13 16  1  0
  6  7  1  0
 16 17  1  0
  7  8  1  0
 17 18  2  0
  8  9  1  0
 18 19  1  0
  9  5  1  0
 19 20  2  0
  4  1  1  0
 20 21  1  0
  8 10  2  0
 21 22  2  0
 22 17  1  0
  5  6  1  0
 20 23  1  0
  9 11  2  0
 15 24  2  0
 11 12  1  0
  7 25  1  0
M  END

Alternative Forms

  1. Parent:

    ALA212045

    ---

Associated Targets(non-human)

Dyrk1a Dual-specificity tyrosine-phosphorylation regulated kinase 1A (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 353.38Molecular Weight (Monoisotopic): 353.0634AlogP: 3.25#Rotatable Bonds: 1
Polar Surface Area: 61.77Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.61CX LogD: 2.61
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.80Np Likeness Score: -1.46

References

1. Kim ND, Yoon J, Kim JH, Lee JT, Chon YS, Hwang MK, Ha I, Song WJ..  (2006)  Putative therapeutic agents for the learning and memory deficits of people with Down syndrome.,  16  (14): [PMID:16698266] [10.1016/j.bmcl.2006.04.042]

Source